E valuating the Folate - Neural Tube Defect Health Claim Pilot

Process Evaluation of the Management Framework

Outcome Evaluation

September 2000

Australia New Zealand Food Authority

 

Contents

Acknowledgments  

Abbreviations          

Part 1-Summary  [ pdf ]     

1           Introduction

1.1        Process evaluation   
1.2        Outcome evaluation            

2           Establishment and implementation of the pilot           

3           Conclusions from the process and outcome evaluations        

3.1        Process evaluation   
3.2        Outcome evaluation            

4           Future directions     

4.1       Process evaluation   
4.2        Outcome evaluation            

Part 2 -Process evaluation of the management framework for the folate neural tube defect health claims pilot: Final report  [ pdf ]

1           Introduction

1.1        Folate - neural tube defect health claim pilot       
1.2        Proposed management framework for health claims    
1.3        Process evaluation   
1.4        Methodology            

2           Implementation of the pilot          

2.1        Establishment and implementation of the pilot
2.2        Costs associated with the pilot      
2.3        Management of the pilot    
2.4        Context for interpreting evaluation findings      

3           Scientific assessment          

3.1        How it worked in the pilot
3.2        Stakeholder perceptions based on the pilot        
3.3        Issues if health claims are permitted more generally    
3.4        Implications for scientific assessment processes            

4           Regulatory system  

4.1        How it worked in the pilot
4.2        Stakeholder perceptions based on the pilot        
4.3        Issues if health claims are permitted more generally    
4.4        Implications for regulatory processes      

5           Surveillance and enforcement      

5.1        How it worked in the pilot
5.2        Stakeholder perceptions based on the pilot        
5.3        Issues if health claims are permitted more generally    
5.4        Implications for surveillance and enforcement processes        

6           Education and communication    

6.1        How it worked in the pilot
6.2        Stakeholder perceptions based on the pilot        
6.3        Issues if health claims are permitted more generally    
6.4        Implications for education and communication processes      

7           Monitoring and evaluation           

7.1        Processes used in the pilot
7.2        Stakeholder perceptions based on the pilot        
7.3        Issues if health claims are permitted more generally    
7.4        Implications for the monitoring and evaluation processes      

8           Overall management framework

8.1        Effectiveness of the management framework     
8.2        Strengths and limitations of the management framework        
8.3        Implications for future use of the management framework     
8.4        Costs associated with the pilot      
8.5        Management of the pilot across Australia and New Zealand  

Part 3 -Outcome evaluation of the folate - neural tube defect health claim pilot: Final report  

1           Introduction

1.1        Neural tube defects and folate      
1.2        Folate - NTD health claim pilot      
1.3        Proposed management framework for health claims    
1.4        Aims of outcomes monitoring and evaluation   

2           Process evaluation of the health claim pilot      

2.1        Implementation of the health claim pilot            
2.2        Survey of food industry      

3           The surveys to evaluate the outcomes of the health claim pilot        

3.1        Methods        
3.2        Results           
3.3        Discussion     

4           Comparison of outcomes survey results with other surveys  

4.1        CSIRO survey of consumer' s knowledge about folate  
4.2        Kellogg' s surveys of consumer' s knowledge about folate       
4.3        Responses to Spina Bifida Association 1300 number    

5           Sales of products with health claims       

5.1        Sales of ready-to-eat breakfast cereals      
5.2        Sales of fruit and vegetables          
5.3        Comparison of food sales with survey responses          

 

6           Overall conclusions from the health claim pilot           

Indications for a folate- NTD health claim           

7           Future indications for monitoring and evaluating health claims      

Part 4 -Appendices  

Appendix 1.1

Pro forma for information provided by food industry on implementation
of folate health claim           

Appendix 1.2

Information provided by food industry on implementation of folate health claim

Appendix 1.3

Folate label information on foods including messages on folate content,
added folate and the health claim

Appendix 2.1

ANZFA Folate/Folic Acid Questions - South Australian Health Monitor and
Eat Well Tasmania Surveys           

Appendix 2.2

Australian Supermarket Institute Survey            

Appendix 2.3

CSIRO questionnaire           

Appendix 3

Tables from analysis of surveys    

Appendix 4

Consumers' Knowledge about Folate:

A report for ANZFA outlining preliminary results from the

CSIRO 1998 - 99 National Dietary Surveys           

Appendix 5

Products with scanned retail sales data available          

Glossary        

References    

 

 

Abbreviations

AFGC	Australian Food and Grocery Council
ANZFA	Australia New Zealand Food Authority
ASI	Australian Supermarket Institute
CATI	Computer-assisted telephone interview
CI	Confidence interval
µg	Microgram
NHMRC	National Health and Medical Research Council
NTD	Neural tube defect
OR	Odds ratio
p-value	Probability value
RDI	Recommended dietary intake
RTEC	Ready-to-eat breakfast cereals
SAHM	South Australian Health Monitor
USFDA	United States Food and Drug Administration